Department of Surgery, University of California, Irvine School of Medicine, Irvine, CA.
Ann Surg. 2017 Oct;266(4):574-581. doi: 10.1097/SLA.0000000000002357.
National examination of open proctectomy (OP), laparoscopic proctectomy (LP), and robotic proctectomy (RP) in pathological outcomes and overall survival (OS).
Surgical management for rectal adenocarcinoma is evolving towards utilization of LP and RP. However, the oncological impacts of a minimally invasive approach to rectal cancer have yet to be defined.
Retrospective review of the National Cancer Database identified patients with nonmetastatic locally advanced rectal adenocarcinoma from 2010 to 2014, who underwent neoadjuvant chemoradiation, surgical resection, and adjuvant therapy. Cases were stratified by surgical approach. Multivariate analysis was used to compare pathological outcomes. Cox proportional-hazard modeling and Kaplan-Meier analyses were used to estimate long-term OS.
Of 6313 cases identified, 53.8% underwent OP, 31.8% underwent LP, and 14.3% underwent RP. Higher-volume academic/research and comprehensive community centers combined to perform 80% of laparoscopic cases and 83% of robotic cases. In an intent-to-treat model, multivariate analysis demonstrated superior circumferential margin negativity rates with LP compared with OP (odds ratio 1.34, 95% confidence interval 1.02-1.77, P = 0.036). Cox proportional-hazard modeling demonstrated a lower death hazard ratio for LP compared with OP (hazard ratio 0.81, 95% confidence interval 0.67-0.99, P = 0.037). Kaplan-Meier analysis demonstrated a 5-year OS of 81% in LP compared with 78% in RP and 76% in OP (P = 0.0198).
In the hands of experienced colorectal specialists treating selected patients, LP may be a valuable operative technique that is associated with oncological benefits. Further exploration of pathological outcomes and long-term survival by means of prospective randomized trials may offer more definitive conclusions regarding comparisons of open and minimally invasive technique.
对开腹直肠切除术(OP)、腹腔镜直肠切除术(LP)和机器人直肠切除术(RP)的病理结果和总生存期(OS)进行全国性检查。
直肠腺癌的外科治疗正在向 LP 和 RP 方向发展。然而,微创方法治疗直肠癌的肿瘤学影响尚未确定。
回顾性分析国家癌症数据库,从 2010 年至 2014 年,确定接受新辅助放化疗、手术切除和辅助治疗的非转移性局部晚期直肠腺癌患者。病例按手术方式分层。采用多变量分析比较病理结果。Cox 比例风险模型和 Kaplan-Meier 分析用于估计长期 OS。
在 6313 例病例中,53.8%的患者接受了 OP,31.8%的患者接受了 LP,14.3%的患者接受了 RP。高容量学术/研究和综合社区中心联合完成了 80%的腹腔镜手术和 83%的机器人手术。在意向治疗模型中,多变量分析表明 LP 比 OP 具有更高的环周切缘阴性率(优势比 1.34,95%置信区间 1.02-1.77,P = 0.036)。Cox 比例风险模型显示 LP 与 OP 相比,死亡风险比更低(风险比 0.81,95%置信区间 0.67-0.99,P = 0.037)。Kaplan-Meier 分析显示 LP 组的 5 年 OS 为 81%,RP 组为 78%,OP 组为 76%(P = 0.0198)。
在有经验的结直肠专家手中,LP 可能是一种有价值的手术技术,与肿瘤学益处相关。通过前瞻性随机试验进一步探索病理结果和长期生存情况,可能会对开放和微创技术的比较得出更明确的结论。